The Imperative of Clinical Trial Diversity: Lessons From the SARS-CoV-2 Pandemic
The National Academy of Science, Engineering, and Medicine recently published a report on the lack of diversity in clinical trials.1 This concern, highlighting the importance of research equity, proved especially relevant during the COVID-19 pandemic.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Amanda Sinderovsky, Eli Y. Adashi Tags: Letter to the Editor Source Type: research
More News: Academies | Clinical Trials | COVID-19 | Internal Medicine | Lessons | Pandemics | SARS | Science